Life‐threatening tardive dyskinesia caused by metoclopramide
Identifieur interne : 003370 ( Istex/Corpus ); précédent : 003369; suivant : 003371Life‐threatening tardive dyskinesia caused by metoclopramide
Auteurs : Samie ; Mary Anne Dannenhoffer ; Susan RozekSource :
- Movement Disorders [ 0885-3185 ] ; 1987.
English descriptors
- KwdEn :
Abstract
A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.
Url:
DOI: 10.1002/mds.870020207
Links to Exploration step
ISTEX:80CA89AAA1B32BFF66F28A438E87CE1D23641835Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Life‐threatening tardive dyskinesia caused by metoclopramide</title><author><name sortKey="Samie" sort="Samie" uniqKey="Samie" last="Samie">Samie</name><affiliation><mods:affiliation>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author><author><name sortKey="Dannenhoffer, Mary Anne" sort="Dannenhoffer, Mary Anne" uniqKey="Dannenhoffer M" first="Mary Anne" last="Dannenhoffer">Mary Anne Dannenhoffer</name><affiliation><mods:affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author><author><name sortKey="Rozek, Susan" sort="Rozek, Susan" uniqKey="Rozek S" first="Susan" last="Rozek">Susan Rozek</name><affiliation><mods:affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:80CA89AAA1B32BFF66F28A438E87CE1D23641835</idno><date when="1987" year="1987">1987</date><idno type="doi">10.1002/mds.870020207</idno><idno type="url">https://api.istex.fr/document/80CA89AAA1B32BFF66F28A438E87CE1D23641835/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003370</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Life‐threatening tardive dyskinesia caused by metoclopramide</title><author><name sortKey="Samie" sort="Samie" uniqKey="Samie" last="Samie">Samie</name><affiliation><mods:affiliation>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author><author><name sortKey="Dannenhoffer, Mary Anne" sort="Dannenhoffer, Mary Anne" uniqKey="Dannenhoffer M" first="Mary Anne" last="Dannenhoffer">Mary Anne Dannenhoffer</name><affiliation><mods:affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author><author><name sortKey="Rozek, Susan" sort="Rozek, Susan" uniqKey="Rozek S" first="Susan" last="Rozek">Susan Rozek</name><affiliation><mods:affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1987">1987</date><biblScope unit="vol">2</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="125">125</biblScope><biblScope unit="page" to="129">129</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">80CA89AAA1B32BFF66F28A438E87CE1D23641835</idno><idno type="DOI">10.1002/mds.870020207</idno><idno type="ArticleID">MDS870020207</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Metoclopramide</term><term>Tardive dyskinesia</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Samie</name><affiliations><json:string>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</json:string></affiliations></json:item><json:item><name>Mary Anne Dannenhoffer</name><affiliations><json:string>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</json:string></affiliations></json:item><json:item><name>Susan Rozek</name><affiliations><json:string>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Tardive dyskinesia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Metoclopramide</value></json:item></subject><language><json:string>eng</json:string></language><abstract>A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.</abstract><qualityIndicators><score>3.412</score><pdfVersion>1.3</pdfVersion><pdfPageSize>504 x 737.759 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>938</abstractCharCount><pdfWordCount>1888</pdfWordCount><pdfCharCount>12371</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>127</abstractWordCount></qualityIndicators><title>Life‐threatening tardive dyskinesia caused by metoclopramide</title><genre><json:string>Serial article</json:string></genre><host><volume>2</volume><pages><total>5</total><last>129</last><first>125</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Case Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1987</publicationDate><copyrightDate>1987</copyrightDate><doi><json:string>10.1002/mds.870020207</json:string></doi><id>80CA89AAA1B32BFF66F28A438E87CE1D23641835</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/80CA89AAA1B32BFF66F28A438E87CE1D23641835/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/80CA89AAA1B32BFF66F28A438E87CE1D23641835/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/80CA89AAA1B32BFF66F28A438E87CE1D23641835/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Life‐threatening tardive dyskinesia caused by metoclopramide</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1987</date></publicationStmt><notesStmt><note type="content">*A videotape segment accompanies this article.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Life‐threatening tardive dyskinesia caused by metoclopramide</title><author><persName><surname>Samie</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, U.S.A.</p></note><affiliation>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation></author><author><persName><forename type="first">Mary Anne</forename><surname>Dannenhoffer</surname></persName><affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation></author><author><persName><forename type="first">Susan</forename><surname>Rozek</surname></persName><affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1987"></date><biblScope unit="vol">2</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="125">125</biblScope><biblScope unit="page" to="129">129</biblScope></imprint></monogr><idno type="istex">80CA89AAA1B32BFF66F28A438E87CE1D23641835</idno><idno type="DOI">10.1002/mds.870020207</idno><idno type="ArticleID">MDS870020207</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1987</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Tardive dyskinesia</term></item><item><term>Metoclopramide</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Case Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1987">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/80CA89AAA1B32BFF66F28A438E87CE1D23641835/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="tocForm">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/mds.v2:2</doi><numberingGroup><numbering type="journalVolume" number="2">2</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="1987">1987</coverDate></publicationMeta><publicationMeta level="unit" type="caseStudy" position="7" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870020207</doi><idGroup><id type="unit" value="MDS870020207"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Case Report</title><title type="tocHeading1">Case Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1987 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2004-10-12"></event><event type="publishedOnlineFinalForm" date="2004-10-12"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">125</numbering><numbering type="pageLast">129</numbering></numberingGroup><correspondenceTo>Department of Neurology, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870020207.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="20"></count></countGroup><titleGroup><title type="main" xml:lang="en">Life‐threatening tardive dyskinesia caused by metoclopramide<link href="#fn1"></link></title><title type="short" xml:lang="en">METOCLOPRAMIDE AND TARDIVE DYSKINESIA</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>M. Reza</givenNames><familyName>Samie</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Mary Anne</givenNames><familyName>Dannenhoffer</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Susan</givenNames><familyName>Rozek</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Tardive dyskinesia</keyword><keyword xml:id="kwd2">Metoclopramide</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>A videotape segment accompanies this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Life‐threatening tardive dyskinesia caused by metoclopramide</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>METOCLOPRAMIDE AND TARDIVE DYSKINESIA</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Life‐threatening tardive dyskinesia caused by metoclopramide</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Samie</namePart><affiliation>Departments of Neurology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation><description>Correspondence: Department of Neurology, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, U.S.A.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Mary Anne</namePart><namePart type="family">Dannenhoffer</namePart><affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Susan</namePart><namePart type="family">Rozek</namePart><affiliation>Departments of Pharmacy, State University of New York at Buffalo, Erie County Medical Center, Buffalo, New York</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">caseStudy</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1987</dateIssued><copyrightDate encoding="w3cdtf">1987</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">20</extent></physicalDescription><abstract lang="en">A case of severe life‐threatening tardive dyskinesia resulting in esophageal and respiratory difficulties due to metoclopramide therapy is presented. A 66‐year‐old man with a primary diagnosis of clear cell carcinoma of the biliary duct was treated with metoclopramide for gastrointestinal symptons related to his chemotherapy regimen. The patients initially presented with tremor and rigidity in the upper extremities. On antiparkinsonian therapy, symptons progressed to hemiballism and involuntary movements of the face, mouth, and tongue, with respiratory and esophageal dyskinesia. Despite discontinuance of metoclopramide, severe tardive dyskinetic symptons resulted in placement of a gastrostomy tube to maintain nutritional support. This case along with other in the literature should emphasize the need for continuous reevaluation of metoclopramide during long‐term therapy, since serious side effects have been reported to occur.</abstract><note type="content">*A videotape segment accompanies this article.</note><subject lang="en"><genre>Keywords</genre><topic>Tardive dyskinesia</topic><topic>Metoclopramide</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Case Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1987</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>125</start><end>129</end><total>5</total></extent></part></relatedItem><identifier type="istex">80CA89AAA1B32BFF66F28A438E87CE1D23641835</identifier><identifier type="DOI">10.1002/mds.870020207</identifier><identifier type="ArticleID">MDS870020207</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1987 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003370 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003370 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:80CA89AAA1B32BFF66F28A438E87CE1D23641835
|texte= Life‐threatening tardive dyskinesia caused by metoclopramide
}}
| This area was generated with Dilib version V0.6.23. |  |